These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 298337)

  • 41. Attenuation of intravenous amphetamine reinforcement by central dopamine blockade in rats.
    Yokel RA; Wise RA
    Psychopharmacology (Berl); 1976 Aug; 48(3):311-8. PubMed ID: 823588
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardiovascular effects of 0.5 milligrams per kilogram oral d-amphetamine and possible attenuation by haloperidol.
    Angrist B; Sanfilipo M; Wolkin A
    Clin Neuropharmacol; 2001; 24(3):139-44. PubMed ID: 11391124
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Variable attenuation of amphetamine effects by lithium.
    Angrist B; Gershon S
    Am J Psychiatry; 1979 Jun; 136(6):806-10. PubMed ID: 443465
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction in plasma norepinephrine during fenfluramine treatment.
    de la Vega CE; Slater S; Ziegler MG; Lake CR; Murphy DL
    Clin Pharmacol Ther; 1977 Feb; 21(2):216-21. PubMed ID: 319936
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Associations between the DBH gene, plasma dopamine β-hydroxylase activity and cognitive measures in Han Chinese patients with schizophrenia.
    Sun Z; Ma Y; Li W; He J; Li J; Yang X; Mao P; Cubells JF; Tang YL
    Schizophr Res; 2018 Mar; 193():58-63. PubMed ID: 28647493
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine.
    Schank JR; Ventura R; Puglisi-Allegra S; Alcaro A; Cole CD; Liles LC; Seeman P; Weinshenker D
    Neuropsychopharmacology; 2006 Oct; 31(10):2221-30. PubMed ID: 16395294
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impaired noradrenergic transmission in schizophrenia?
    van Kammen DP; Antelman S
    Life Sci; 1984 Apr; 34(15):1403-13. PubMed ID: 6323903
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hydrochlorothiazide-induced sympathetic hyperactivity in hypertensive patients.
    Lake CR; Ziegler MG; Coleman MD; Kopin IJ
    Clin Pharmacol Ther; 1979 Oct; 26(4):428-32. PubMed ID: 487689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of pimozide on the acquisition, maintenance, and extinction of an amphetamine-induced taste aversion.
    Grupp LA
    Psychopharmacology (Berl); 1977 Aug; 53(3):235-42. PubMed ID: 408851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Atypical neuroleptics clozapine and thioridazine enhance amphetamine-induced stereotypy.
    Robertson A; MacDonald C
    Pharmacol Biochem Behav; 1984 Jul; 21(1):97-101. PubMed ID: 6540455
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuation by pimozide of the suppressant effect of d-amphetamine on operant behaviour.
    Morley MJ; Bradshaw CM; Szabadi E
    Psychopharmacology (Berl); 1987; 91(2):239-43. PubMed ID: 3107040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dopamine-beta-hydroxylase, monoamine oxidase, and schizophrenia.
    DeLisi LE; Wise CD; Potkin SG; Zalcman S; Phelps BH; Lovenberg W; Wyatt RJ
    Biol Psychiatry; 1980 Dec; 15(6):895-907. PubMed ID: 7459411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A genetic study of plasma dopamine beta-hydroxylase in affective disorder.
    Levitt M; Mendlewicz J
    Mod Probl Pharmacopsychiatry; 1975; 10():89-98. PubMed ID: 1177948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dopamine beta-hydroxylase and plasma renin activity in patients with low-, normal-, and high-renin essential hypertension.
    Lawton WJ; Fitz A; Grant C; Witte DL
    Circulation; 1979 May; 59(5):1063-9. PubMed ID: 428086
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Motility response to morphine and amphetamine during chronic inhibition of tyrosine hydroxylase or dopamine beta-hydroxylase.
    Khalsa JH; Davis WM
    J Pharmacol Exp Ther; 1977 Jul; 202(1):182-91. PubMed ID: 17725
    [No Abstract]   [Full Text] [Related]  

  • 56. Norepinephrine-deficient mice exhibit normal sleep-wake states but have shorter sleep latency after mild stress and low doses of amphetamine.
    Hunsley MS; Palmiter RD
    Sleep; 2003 Aug; 26(5):521-6. PubMed ID: 12938804
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroleptic drug effect on plasma dopamine-beta-hydroxylase in schizophrenia.
    Baron M; Gruen R; Levitt M; Kane J
    Neuropsychobiology; 1982; 8(6):312-4. PubMed ID: 6131392
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Noradrenergic role in the self-administration of morphine or amphetamine.
    Davis WM; Smith SG; Khalsa JH
    Pharmacol Biochem Behav; 1975; 3(3):477-84. PubMed ID: 168592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of pimozide and phenoxybenzamine pretreatments on amphetamine and apomorphine potentiation of the acoustic startle response in rats.
    Kehne JH; Sorenson CA
    Psychopharmacology (Berl); 1978 Jul; 58(2):137-44. PubMed ID: 98780
    [No Abstract]   [Full Text] [Related]  

  • 60. Proceedings: Comparison of the effects of dexamphetamine and 1-benzylpiperazine in former addicts.
    Campbell H; Cline W; Evans M; Lloyd J; Peck AW
    Br J Pharmacol; 1972 Feb; 44(2):369P-370P. PubMed ID: 4588221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.